Literature DB >> 17551307

Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload.

Sukesh C Burjonroppa1, Ann T Tong, Lian-Chun Xiao, Marcella M Johnson, S Wamique Yusuf, Daniel J Lenihan.   

Abstract

OBJECTIVES: Elevated B-type natriuretic peptide (BNP) levels are established as a marker for volume overload and left ventricular (LV) dysfunction in patients with predominately cardiac diseases. Little is known about markedly elevated BNP values in patients with multiple comorbidities.
METHODS: A total of 99 patients, admitted to M. D. Anderson Cancer Center, were identified as having a BNP value >1000 pg/mL during the year 2003. Clinical characteristics, including the presence of volume overload and sepsis, as well as echocardiographic parameters were measured. Principal outcome was defined as 30-day mortality.
RESULTS: The median BNP (pg/mL) of the group was 2270 (range, 1010-5000), and there was no association between elevation of the BNP level and the presence of volume overload or LV dysfunction (P = not significant). The large majority of patients (n = 71, 72%) had no volume overload and normal or nearly normal LV function (n = 60, 61%). A majority were also identified as having sepsis (n = 52, 53%). There was no echocardiographic parameter that consistently correlated with BNP levels or volume overload. There was a highly significant association with sepsis and mortality in patients with markedly elevated BNP values, and this conferred a 2.71-fold increased risk of mortality.
CONCLUSIONS: In patients admitted with multiple comorbidities and markedly elevated BNP values, there is no significant association with clinical evidence of volume overload or LV dysfunction. An elevated BNP level in patients with sepsis was significantly associated with mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551307     DOI: 10.1097/01.coc.0000256101.04404.b0

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  18 in total

Review 1.  Pay attention to cardiac remodeling in cancer cachexia.

Authors:  Yawen Zheng; Han Chen; Xiaoqing Li; Yuping Sun
Journal:  Support Care Cancer       Date:  2016-04-23       Impact factor: 3.603

2.  Association Between Plasma Brain Natriuretic Peptide and Overall Survival in Patients With Advanced Cancer: Preliminary Findings.

Authors:  David Hui; Jane Naberhuis; Seyedeh Dibaj; Mujtaba Naqvi; Diane Liu; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2019-05-22       Impact factor: 3.612

3.  Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.

Authors:  Daniel R Gomez; Syed Wamique Yusuf; Mark F Munsell; James W Welsh; Zhongxing Liao; Steven H Lin; Hubert Y Pan; Joe Y Chang; Ritsuko Komaki; James D Cox; Mary Frances McAleer; David R Grosshans
Journal:  J Thorac Oncol       Date:  2014-10       Impact factor: 15.609

Review 4.  Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers.

Authors:  Michela Chianca; Giorgia Panichella; Iacopo Fabiani; Alberto Giannoni; Serena L'Abbate; Alberto Aimo; Annamaria Del Franco; Giuseppe Vergaro; Chrysanthos Grigoratos; Vincenzo Castiglione; Carlo Maria Cipolla; Antonella Fedele; Claudio Passino; Michele Emdin; Daniela Maria Cardinale
Journal:  Front Cardiovasc Med       Date:  2022-07-06

Review 5.  Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Vivek Narayan; Elizabeth W Thompson; Biniyam Demissei; Jennifer E Ho; James L Januzzi; Bonnie Ky
Journal:  J Am Coll Cardiol       Date:  2020-06-02       Impact factor: 24.094

Review 6.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

7.  Use of N-terminal pro-brain natriuretic peptide to detect cardiac origin in critically ill cancer patients with acute respiratory failure.

Authors:  Aurélie Lefebvre; Suzanne Kural-Menasché; Michael Darmon; Guillaume Thiéry; Jean-Paul Feugeas; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

8.  N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.

Authors:  José Tuñón; Javier Higueras; Nieves Tarín; Carmen Cristóbal; Óscar Lorenzo; Luis Blanco-Colio; José Luis Martín-Ventura; Ana Huelmos; Joaquín Alonso; Álvaro Aceña; Ana Pello; Rocío Carda; Dolores Asensio; Ignacio Mahíllo-Fernández; Lorenzo López Bescós; Jesús Egido; Jerónimo Farré
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

Review 9.  Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors:  Alan H Baik; Katy K Tsai; David Y Oh; Mandar A Aras
Journal:  Clin Sci (Lond)       Date:  2021-03-12       Impact factor: 6.124

10.  Brain natriuretic Peptide production and secretion in inflammation.

Authors:  Tsuneo Ogawa; Adolfo J de Bold
Journal:  J Transplant       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.